The largest database of trusted experimental protocols

12 protocols using lc 30ad system

1

Rapid LC-MS/MS Quantification of Analytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reconstituted samples were analyzed directly via LC-MS/MS in negative ion mode with the SMRM, using ±0.5 min windows around expected retention times. The SMRM table is reported in Table 1. Samples were analyzed by liquid chromatography on a Shimadzu LC-30AD system coupled to a triple quadrupole mass spectrometer (QTRAP5500, AB SCIEX, Framingham, MA, USA). A 15 µL volume of each extract was injected into the LC-MS/MS system. Electrospray ionization was performed with the following optimized source parameters: curtain gas, 20 psi; ionization spray voltage, −4500 V; probe temperature, 450 °C; ion source gas 1, 50 psi; ion source gas 2, 50 psi; entrance potential, −10 V. Chromatographic separation was achieved on a Kinetex C18 (2.1 × 100 mm, 1.7 µm) reverse-phase column at a flow rate of 0.6 mL/min at 40 °C during a 4-min gradient. Mobile phase A contained 0.1% acetic acid in water and mobile phase B contained 0.1% acetic acid in acetonitrile. The solvent gradient at a flow rate of 0.6 mL/min started with 30% B, increased to 60% B in 0.7 min, held constant for 1.4 min, then increased to 95% in 0.2 min, held constant for 0.6 min, reduced to 30% B in 0.1 min, followed by equilibration at 30% B for 1 min.
+ Open protocol
+ Expand
2

UPLC-MS/MS Analysis of Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The liquid chromatogram analysis was performed on a Shimadzu LC-30AD system (Shimadzu, Kyoto, Japan). ACQUITY UPLC BEH C8 column (Waters, 1.7 μm, 2.1 × 100 mm) was used for separation. Mobile phase A consisted of a mixture of water:methanol:acetonitrile (3:1:1, v/v/v) while mobile phase B was isopropanol, with both containing 5 mM ammonium acetate. The mobile phase flow rate was 0.3 ml/min, sample injection volume was 2 μl, and elution conditions were as follows: 0–0.5 min, 20% B; 0.5–1.5 min, 20–40% B; 1.5–3 min, 40–60% B; 3–13 min, 60–100% B; 13–14 min, 100% B; 14–17 min, 20% B.
Mass spectrometry was conducted on a triple quadrupole linear ion trap mass spectrometer (QTRAP 6500+) (AB SCIEX, Framingham, MA, United States) coupled with an ESI source. Scheduled multi-reaction monitoring (MRM) with chosen time windows under either positive or negative ion modes was utilized for acquire for the acquisition of chromatograms. MS parameters were configured with gas temperature at 400°C, ion spray voltage at 5,500 V, and with the ion source gas I (GSI), the gas II (GSII), and the curtain gas (CUR) corresponding to 50, 50, and 35 psi respectively.
+ Open protocol
+ Expand
3

UHPLC-MS/MS Analysis of Molecular Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPLC analysis was performed on a Shimadzu LC-30AD system (Shimadzu, Kyoto, Japan) which consist of two interconnected pump units: one with an integrated degasser and the other with a mixer, and is comprised of a UHPLC gradient system, a refrigerated autosampler, and a column oven compartment. Mass spectrometric detection was performed on an AB SCIEX QTRAP® 5500 (AB SCIEX instruments, Foster, CA, USA) in MRM mode and EPI mode. A Turbo V™ Ion Source (ESI) interface in positive ionization mode was used. Both the UHPLC and mass spectrometer were controlled remotely using Analyst® software v. 1.6.2 (AB SCIEX instruments, Foster City, CA, USA). A Waters BEH C18 column (1.7 µm 2.1 mm × 100 mm, Waters, Milford, MA, USA) was applied for analysis. The mass spectrometer was equipped with an electrospray ionization source and spectra were acquired in the positive ion multiple reaction monitoring (MRM) mode and enhanced product ion (EPI) scan modes. MS was optimized using a capillary voltage of 5.50 kV and desolvation temperature of 500 °C. The cone gas pressure and desolvation gas pressure were 50 psi. Nitrogen was used as the cone and collision gasses, respectively. The raw data were analyzed using an Analyst 1.6.2 workstation (AB SCIEX, Foster, CA, USA).
+ Open protocol
+ Expand
4

Extraction and LC-MS/MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in 1 mL TCEP solution and then incubated for 10 min at laboratory temperature and sonicated for 2 × 1 min in a pulse mode. 200 μL of cell lysate was transferred to a vial containing 800 μL methanol + 1% FA and vortexed for 10 s and then stored at −20°C for 2 h. The sample was centrifuged at 13000 rpm for 10 min at 4°C and the supernatants were pipetted and filtered through a 0.22-μm filter and placed into vials for LC-MS/MS analysis. The LC-MS/MS analysis was performed using a LCMS-8050 triple quadrupole mass spectrometer (Shimadzu, Kyoto, Japan) equipped with an LC-30AD system (Shimadzu, Kyoto, Japan) and SIL-30AD autosampler (Shimadzu, Kyoto, Japan). Chromatographic separation was performed using gradient elution on a reversed-phase UPLC XSelect HSS T3 1.8 μm, 100 × 2.1 mm I.D. column (Waters, Milford, MA, USA). The mobile phases were as follows: A, 10 mM ammonium acetate in water and B, 20% (v/v) acetonitrile in methanol. The flow rate was 0.3 mL/min. The gradient employed was as follows: 0.01–1.5 min started at 5% B, 1.5–6 min from 5% to 50% B, 6–6.1 min from 50% to 95% B and hold for 2 min, and 8–9 min from 95% to 5% B and hold for 4 min. The total time was 13 min. The sample temperature in the autosampler was maintained at 4°C, and the injection volume was 1 μL in each run.
+ Open protocol
+ Expand
5

Quantification of Antiepileptic Drugs by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma concentration of each drug was measured by LC-MS/MS based on the ESI (electrospray ionization) method. The LC-MS/MS system consisted of a high-performance liquid chromatograph LC-30AD system (Shimadzu, Kyoto, Japan) and an AB Sciex QTRAP 6500 tandem mass spectrometer (Framingham, MA, USA). Capcell Pak C18 MGII (particle size 5 μm, inner diameter 2.0 mm x 50 mm; Osaka Soda, Osaka, Japan) was used as the separation column. To measure the concentration of SVA, solvent A (water containing 0.063% ammonium formate) and solvent B (acetonitrile) were used as the mobile phase. The gradient conditions were maintained at 20% solvent B for 1.5 min, increased from 20% to 95% solvent B in 1.50 min, held at 95% for 1.0 min, decreased back to 20% within 0.01 min, and held at 20% for 1.49 min. To measure the concentration of LEV and CBZ, solvent A (water containing 0.1% formic acid) and solvent B (acetonitrile) were used as the mobile phase. The gradient conditions of LEV were increased from 5% to 60% solvent B in 1.50 min, sharply increased to 95% within 0.01 min, held at 95% for 1.49 min, decreased back to 5% within 0.01 min, and held at 5% for 1.49 min. The gradient conditions of CBZ were increased from 30% to 95% solvent B in 2.00 min, held at 95% for 1.00 min, decreased back to 30% within 0.01 min, and held at 30% for 1.49 min.
+ Open protocol
+ Expand
6

LC-MS/MS Quantification of Anthocyanins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthocyanins were determined by LC-MS/MS analysis using a Shimadzu LC 30AD system combined with a Shimadzu 8030+ MS detector with an electrospray ionization (ESI) source. The separation of anthocyanins was made at 40 °C with a Zorbax Eclipse Plus C18—2.1 mm × 50 mm–1.8 µm column (Agilent Technology, Santa Clara, CA, USA). The mobile phase consisted of aqueous 0.5% formic acid (A) and methanol 0.5% formic acid (B). The flow rate was set at 0.5 mL/min. The samples were eluted using a linear gradient: 0–1 min, 15% B; 1–5 min, 15–50% B; 5–5.1 min, 50–100% B; 5.1–6.0 min, 100% isocratic; 6.0–6.1 min, 100–15% B. The sample injection volume was set at 5 µL. All the MS/MS parameters were optimized by the infusion of each of the standards (1 µg/mL) and the optimal ionization conditions and fragmentation patterns were determined using instrument software (Labsolutions, Shimadzu, Kyoto, Japan). Multiple reaction monitoring (MRM) parameters for each anthocyanin standard are presented in Table 1. In the positive ion mode, the mass spectrometry conditions were as follow: nebulizer gas flow, 2 L/min; drying gas flow, 10 L/min; heating block temperature 400 °C; DL temperature 250 °C; and mass range from 50 to 1200 m/z. Standard calibration curves were constructed for all analytes and the concentration of anthocyanins in the samples was determined using regression analysis (R2 > 0.99).
+ Open protocol
+ Expand
7

Protein Purification and HPLC-MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
High performance liquid chromatography analysis was carried out with an LC-30AD system (Shimadzu, Japan). The purified protein samples in PBS were held at room temperature, and the injection volume was 10 μl. The chromatography column was an Agilent Poroshell 300SB-C8 (1.0 × 75 mm, 5 μm). The flow rate was 0.3 ml/min in gradient mode with 0.1% formic acid (A) and acetonitrile (B). The equilibrium time after the run was 25 min. Gradient conditions were as follows: 0–5.0 min, 5% B; 5.0–20.0 min, 5%–80% B; 20.0–25.0, 80% B. The column temperature was maintained at 60 °C. Mass spectral analysis was performed on a Triple TOF 4600 mass spectrometer (Sciex, America) equipped with an electrospray ionization (ESI) source and operated in positive ion mode. A calibration solution was used to calibrate the instrument. The curtain gas (CUR), nebulizer gas (GS1) and turbo gas (GS2) were set at 35 psi, 55 psi and 55 psi, respectively. The electrospray voltage was 5.5 kV, and the turbo ion spray source temperature was 550 °C. Nitrogen was employed as the collision gas. The mass spectrometer operated in the TOF-MS full scan mode with a 500–4000 m/z range. Data acquisition was performed using Analyst 1.6.2 software (Applied Biosystems). The Bayesian protein reconstruction tool was used to calculate protein molecules.
+ Open protocol
+ Expand
8

Pharmacokinetics of NU6300 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male BALB/c mice were randomly divided into two groups (n = 3) to receive either intravenous (20 mg/kg) or intraperitoneal (20 mg/kg) administration of NU6300. Blood samples (20 μl each time) were collected from the posterior orbital venous plexus at 5, 15, and 30 min and 1, 2, 4, 6, 8, 10, and 24 hours after administration. Plasma samples were obtained by centrifugation (3500 rpm, 4°C, 15 min), and then the concentration of NU6300 in plasma was determined by LC-MS/MS analysis. Standard curve for NU6300 in plasma was generated by adding various concentrations, including an internal standard, to blank plasma. The Shimadzu LC-30 AD system was used for separation, with a mobile phase of ACN/0.1% formic acid at a flow rate of 0.5 ml/min. All blood samples were centrifuged and quantified using the Shimadzu LC-30 AD system coupled with AB SCIEX 5500 QTRAP mass spectrometer. Pharmacokinetic parameters were calculated using DAS 2.0.
+ Open protocol
+ Expand
9

Comprehensive LC-MS/MS Protocol for Compound Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analyses were performed on LS-MS/MS analyses with a Shimadzu LC-30AD system coupled with a Shimadzu MS-8060 mass spectrometer (Kyoto, Japan). ZORBAX SB-C18 column (50 mm × 2.1 mm × 1.8 µm) was purchased from Agilent (Santa Clara, CA, USA). CPA224S electronic analytical balance was purchased from Sartorius Company (Göttingen, Germany). The refrigerator was obtained from Siemens (Munich, Germany). The HITACHI CT6E centrifuge was purchased from Hitachi, Ltd. (Tokyo, Japan). The 80350-CN grinder was supplied by Hamilton Beach Electric Co., Ltd. (Shenzhen, China). A DFT-100A portable high-speed universal crusher was purchased from Linda Machinery Co., Ltd. (Wenling, China). The HQ-60 vortex mixer was purchased from North Tongzheng Biotechnology Co., Ltd. (Beijing, China). The DTC-27J ultrasonic cleaner was provided by Dingtai Biochemical Technology Equipment Manufacturing Co., Ltd. (Wuhan, China). SPE column (Mega BE-SI, 1 g, 6 mL) was purchased from Agilent (Santa Clara, CA, USA). Pipettes (10 µL, 200 µL, 1 mL, 5 mL) were purchased from Eppendorf Company (Hamburg, Germany). A 1 mL syringe was purchased from Wangguan Medical Devices Co., Ltd. (Wuhan, China). A 0.22 µm organic phase filter was purchased in Millipore Company (Burlington, MA, USA).
+ Open protocol
+ Expand
10

UHPLC-MS/MS Analysis of Bioactive Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ultrahigh performance liquid chromatography (UHPLC) analysis was performed using Shimadzu LC-30AD system (Shimadzu, Kyoto, Japan). Separation was fulfilled by using ACQUITY UPLC BEH C18 column (Waters, 1.7 μm, 2.1 × 100 mm). The mobile phase was composed of 0.1% Formic acid-water (A) and acetonitrile (B). The gradient elution was set as follows: 0−6 min, 5–95% B; 6−7 min, 95−95% B; 7−8 min, 95−95% B; 8−9 min, 5−5% B. The flow rate was set as 0.3 mL/min, and the injection volume was 2 μL.
Mass spectrometry was performed with a triple quadrupole linear ion trap mass spectrometer (QTRAP 6500+) (AB SCIEX, Framingham, MA, USA) equipped with an ESI source. The general MS parameters were set as follows: gas temperature, 400 °C; ion spray voltage, 5500 V; GS1 and GS2, both 50 psi; and CUR, 35 psi. The mass spectrum conditions of the eight main components are shown in Table 1.

MS parameters of the target analytes.

Table 1
CompoundsRT (min)Precursor Ion (m/z)Product Ion (m/z)Cone voltage (V)Collision Energy (V)
asperulosidic acid5.3432.12119.12340.93
syringic acid3.23198.057835.8814.16
emodin6.33270.0522534.27144.08
salicylic acid3.48138.0392.92129.68
ferulic acid2.53194.0578.826105
betaine0.86385.3058.133.6383.93
scopoletin3.46353.27103.932.9836
chlorogenic acid2.93354.09191.119.0824
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!